Editorial
Latent autoimmune diabetes in adults: are we paying sufficient attention?
Diabetes autoinmune latente del adulto: ¿estamos prestando suficiente atención?
Leído
2712
Vecesse ha leído el artículo
654
Total PDF
2058
Total HTML
Compartir estadísticas
array:22 [ "pii" => "S2173509315000033" "issn" => "21735093" "doi" => "10.1016/j.endoen.2014.12.003" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "648" "copyright" => "SEEN" "copyrightAnyo" => "2014" "documento" => "article" "subdocumento" => "sco" "cita" => "Endocrinol Nutr. 2015;62:1-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1098 "formatos" => array:3 [ "EPUB" => 11 "HTML" => 805 "PDF" => 282 ] ] "Traduccion" => array:1 [ "es" => array:18 [ "pii" => "S1575092214003015" "issn" => "15750922" "doi" => "10.1016/j.endonu.2014.12.001" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "648" "copyright" => "SEEN" "documento" => "article" "subdocumento" => "sco" "cita" => "Endocrinol Nutr. 2015;62:1-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2253 "formatos" => array:3 [ "EPUB" => 22 "HTML" => 1726 "PDF" => 505 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Latent autoimmune diabetes in adults: are we paying sufficient attention?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1" "paginaFinal" => "3" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Diabetes autoinmune latente del adulto: ¿estamos prestando suficiente atención?" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Marta Hernández, Dídac Mauricio" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Marta" "apellidos" => "Hernández" ] 1 => array:2 [ "nombre" => "Dídac" "apellidos" => "Mauricio" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S2173509315000033" "doi" => "10.1016/j.endoen.2014.12.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509315000033?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1575092214003015?idApp=UINPBA00004N" "url" => "/15750922/0000006200000001/v1_201501110106/S1575092214003015/v1_201501110106/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S2173509314001895" "issn" => "21735093" "doi" => "10.1016/j.endoen.2014.11.008" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "627" "copyright" => "SEEN" "documento" => "article" "subdocumento" => "fla" "cita" => "Endocrinol Nutr. 2015;62:4-10" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1521 "formatos" => array:3 [ "EPUB" => 16 "HTML" => 1215 "PDF" => 290 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original</span>" "titulo" => "Reference ranges for serum and salivary testosterone in young men of Mediterranean region" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "4" "paginaFinal" => "10" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Valores de referencia de testosterona sérica y salivar en varones jóvenes del área Mediterránea" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1475 "Ancho" => 1352 "Tamanyo" => 145915 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Age distribution on percentages of the sample compared to general population.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Víctor González-Sánchez, Oscar Moreno-Pérez, Luis García de Guadiana, Pedro Sánchez-Pellicer, Rocío Alfayate, Montserrat Mauri, José Sánchez-Payá, Antonio Picó" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Víctor" "apellidos" => "González-Sánchez" ] 1 => array:2 [ "nombre" => "Oscar" "apellidos" => "Moreno-Pérez" ] 2 => array:2 [ "nombre" => "Luis" "apellidos" => "García de Guadiana" ] 3 => array:2 [ "nombre" => "Pedro" "apellidos" => "Sánchez-Pellicer" ] 4 => array:2 [ "nombre" => "Rocío" "apellidos" => "Alfayate" ] 5 => array:2 [ "nombre" => "Montserrat" "apellidos" => "Mauri" ] 6 => array:2 [ "nombre" => "José" "apellidos" => "Sánchez-Payá" ] 7 => array:2 [ "nombre" => "Antonio" "apellidos" => "Picó" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1575092214002289" "doi" => "10.1016/j.endonu.2014.09.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1575092214002289?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509314001895?idApp=UINPBA00004N" "url" => "/21735093/0000006200000001/v1_201501180031/S2173509314001895/v1_201501180031/en/main.assets" ] "es" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Latent autoimmune diabetes in adults: are we paying sufficient attention?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1" "paginaFinal" => "3" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Marta Hernández, Dídac Mauricio" "autores" => array:2 [ 0 => array:3 [ "nombre" => "Marta" "apellidos" => "Hernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:4 [ "nombre" => "Dídac" "apellidos" => "Mauricio" "email" => array:1 [ 0 => "didacmauricio@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Department of Endocrinology & Nutrition, University Hospital Arnau de Vilanova, Rovira Roure, 80, 25198 Lleida, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Department of Endocrinology & Nutrition, University Hospital & Health Sciences Research Institute Germans Trias i Pujol, Carretera de Can Ruti, S/N, 08916 Badalona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Autor para correspondencia." ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Diabetes autoinmune latente del adulto: ¿estamos prestando suficiente atención?" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Heterogeneity has been recently highlighted as a relevant characteristic of diabetes mellitus<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a>. The current classification of diabetes mellitus includes two main types of the disease, i.e. type 1 and type 2 diabetes<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a>. The latter is by far the most prevalent one. Nevertheless, there is a significant proportion of subjects with autoimmune diabetes mellitus that are classified as type 2 diabetic patients. These patients are usually known to carry latent autoimmune diabetes in adults (LADA)<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a>. As this subtype of diabetes is not accepted in the current classification of diabetes mellitus, subjects with LADA are classified as type 2 diabetes based on their clinical phenotypic characteristics. However, from the clinical point of view, it is really relevant to adequately characterize these diabetic patients<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a>.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The criteria traditionally accepted by clinicians for the diagnosis of LADA are based on previous consensus<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,4</span></a>: presence of classical type 1 diabetes-associated circulating antibodies, age at diagnosis of at least 30 years, and treatment with non-insulin hypoglycaemic agents during the initial 6 months of the disease. However, the age and treatment requirements are clearly arbitrary in nature. For example, subjects younger than 30 years of age may present with a slowly-progressive form of autoimmune diabetes that is not distinguishable from older patients with LADA<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a>. Further, the decision on whether a patient is put on insulin is largely dependent on the treating clinician's judgment<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a>. Therefore, only the presence of antibodies against islet antigens is an objective requirement. Although other antibodies may be also present in subjects with LADA, if any, antibodies to glutamic acid decarboxylase 65 (GAD) are the most frequently used in clinical practice to assess the presence or absence of islet autoimmunity in patients with type 2 diabetes<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,4</span></a>.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The prevalence of LADA varies between 2-10% of patients with diabetes<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,3,4</span></a>, and this frequency is partly dependent on different characteristics of the design of the research studies that have been published so far. Notwithstanding this subtype of diabetes is not accepted as a different entity in the current clinical classification of diabetes mellitus, the number of subjects affected by the disease is probably higher than the total number of patients with other diabetes types, e.g. type 1 diabetes. Thus, because of its prevalence LADA represents an important clinical issue that should be properly addressed. For the time being, it seems that there is a low awareness of this problem, especially among primary care physicians.</p><p id="par0020" class="elsevierStylePara elsevierViewall">It is well-known that subjects with LADA have differential clinical, metabolic and genetic characteristics<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6–9</span></a>. Fortunately, increasing scientific evidence is accumulating on different aspects of LADA; however, the number of studies are still insufficient, especially if we take into account that this condition was already recognized in the late 70s of the 20th Century. For instance, a PubMed search using the terms ‘LADA’ and ‘diabetes’ yielded only 359 references (accessed December 7<span class="elsevierStyleSup">th</span>, 2014). Yet, a lot should be done to fully characterize this subset of patients in terms of the pathogenesis of LADA, its natural history, the therapeutical approach and its epidemiological features. Thus, it seems that the research interest on LADA is still insufficient.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Concerning their clinical profile, patients with LADA show differential features when compared with type 1 and type 2 diabetic patients<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,8,9</span></a>. In relation to the frequency and the components of the metabolic syndrome, the characteristics of LADA are intermediate between type 1 and type 2 diabetes<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,8,9</span></a>. Additionally, patients with LADA are younger, and have lower adiposity and <span class="elsevierStyleSmallCaps">C</span>-peptide secretion than their antibody-negative type 2 diabetic counterparts<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,9</span></a>. Thus, they usually have a more rapid progression to an insulin-deficient state that manifests frequently as proneness to ketosis and the earlier need of insulin treatment<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,4</span></a>. Importantly, patients with LADA show poorer glycaemic control than type 2 diabetic patients despite the higher frequency of insulin treatment. Several pieces of evidence show that patients with high antibody titres have a low residual insulin secretory capacity and progress more rapidly to insulin dependence<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,8,10</span></a>. All these features have obvious implications in the clinical setting as to the importance of an early identification of these subjects. This is a solid argument that speaks in favour of the clinical use of GAD antibody measurement in the routine diagnostic work-up of patients with newly-diagnosed diabetes.</p><p id="par0030" class="elsevierStylePara elsevierViewall">There is insufficient data concerning the development of complications in patients with LADA. Recent data points to a similar risk of microvascular complications<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a>. The same study showed that the development of cardiovascular complications is not different from subjects with type 2 diabetes. This is noteworthy if we take into account that patients with LADA have a lower burden of associated cardiovascular risk factors. This indicates that in LADA subjects the cardiovascular risk treatment approach should be at least as intensive as in type 2 diabetic patients.</p><p id="par0035" class="elsevierStylePara elsevierViewall">The time of insulin initiation in patients with LADA depends on the intensity of the autoimmune process, the natural history of the disease and especially on the bias of each treating physician<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,9</span></a>. In the Action LADA study in Europe, we could demonstrate that the time to insulin initiation in these subjects is largely dependent on the local clinical judgment<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a>. In those centres that included the use of GAD autoantibody assessment in the routine diagnostic work-up patients with LADA where treated much earlier with insulin<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a>. The use of the GAD antibody determination is a widespread tool in many specialized centres, but this is not the case in the primary care setting where most subjects with LADA are seen at least during the initial stages of the disease process.</p><p id="par0040" class="elsevierStylePara elsevierViewall">There is not enough evidence on which is the best approach to the treatment of hyperglycaemia in patients with LADA. Following the current treatment guidelines, the vast majority of patients receive metformin as the initial hypoglycaemic agent of choice<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a>. Pioglitazone, an agent that also targets insulin resistance, also proved to be useful in the treatment of LADA patients<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a>. As compared to sulphonylureas, intensive insulin treatment has been shown to better preserve residual insulin secretion in patients with LADA as add-on metformin or other oral non-sulphonylurea agents<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a>. Current evidence points to the fact that insulin should preferably be introduced as a further step after metformin instead of a sulphonylurea drug<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a>. Recently, sitagliptin was found to be effective in maintaining beta-cell function as add-on to insulin in a small trial<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a>. However, much more evidence is needed concerning the adequate treatment approach in LADA. Thus, the available evidence points to the clinical utility of identifying these patients allowing for a better hypoglycaemic treatment choice.</p><p id="par0045" class="elsevierStylePara elsevierViewall">In conclusion, the awareness on LADA as an important clinical and research issue among diabetologists and primary care physicians is low. We strongly believe that there is now sufficient evidence to recommend the routine clinical use of GAD autoantibodies in the diagnostic work-up of diabetes mellitus. The timely identification of LADA has clear implications in terms of treatment decisions and clinical follow-up of these patients. Also, much more research efforts should be devoted to the characterization of these patients. We believe that clinicians and researchers should pay much more attention to this condition.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2014-12-09" "fechaAceptado" => "2014-12-10" "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Hernández M, Mauricio D. Diabetes autoinmune latente del adulto: ¿estamos prestando suficiente atención?. Endocrinol Nutr. 2014;62:1–3.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:15 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The many faces of diabetes: a disease with increasing heterogeneity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T. Tuomi" 1 => "N. Santoro" 2 => "S. Caprio" 3 => "M. Cai" 4 => "J. Weng" 5 => "L. Groop" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(13)62219-9" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2014" "volumen" => "383" "paginaInicial" => "1084" "paginaFinal" => "1094" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24315621" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and classification of diabetes mellitus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "American Diabetes" 1 => "Association" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc14-S081" "Revista" => array:7 [ "tituloSerie" => "Diabetes Care" "fecha" => "2014" "volumen" => "37" "numero" => "suppl.1" "paginaInicial" => "S81" "paginaFinal" => "S90" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24357215" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diabetes classification: grey zones, sound and smoke: Action LADA 1" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.D. Leslie" 1 => "H. Kolb" 2 => "N.C. Schloot" 3 => "R. Buzzetti" 4 => "D. Mauricio" 5 => "A. De Leiva" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/dmrr.877" "Revista" => array:6 [ "tituloSerie" => "Diabetes Metab Res Rev." "fecha" => "2008" "volumen" => "24" "paginaInicial" => "511" "paginaFinal" => "519" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18615859" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Latent autoimmune diabetes in adults" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R.G. Naik" 1 => "B.M. Brooks-Worrell" 2 => "J. Palmer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2009-1120" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2009" "volumen" => "94" "paginaInicial" => "4635" "paginaFinal" => "4644" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19837918" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Time to insulin initiation cannot be used in defining autoimmune diabetes in adults" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Brophy" 1 => "K. Yderstraede" 2 => "D. Mauricio" 3 => "S. Hunter" 4 => "M. Hawa" 5 => "P. Pozzilli" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc07-1308" "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "2008" "volumen" => "31" "paginaInicial" => "439" "paginaFinal" => "441" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18083788" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "N. Hosszúfalusi" 1 => "A. Vatay" 2 => "K. Rajczy" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "2003" "volumen" => "26" "paginaInicial" => "452" "paginaFinal" => "457" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12547879" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metabolic syndrome and autoimmune diabetes: action LADA 3" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.I. Hawa" 1 => "C. Thivolet" 2 => "D. Mauricio" 3 => "I. Alemanno" 4 => "E. Cipponeri" 5 => "D. Collier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc08-1419" "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "2009" "volumen" => "32" "paginaInicial" => "160" "paginaFinal" => "164" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18945926" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Mollo" 1 => "M. Hernández" 2 => "J.R. Marsal" 3 => "A. Esquerda" 4 => "F. Rius" 5 => "F. Blanco-Vaca" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/dmrr.2411" "Revista" => array:6 [ "tituloSerie" => "Diabetes Metab Res Rev" "fecha" => "2013" "volumen" => "29" "paginaInicial" => "446" "paginaFinal" => "451" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23483713" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype. Action LADA 7" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.I. Hawa" 1 => "H. Kolb" 2 => "N. Schloot" 3 => "N. Beyan" 4 => "S.A. Paschou" 5 => "R. Buzzetti" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc12-0931" "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "2013" "volumen" => "36" "paginaInicial" => "908" "paginaFinal" => "913" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23248199" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Liu" 1 => "X. Li" 2 => "G. Xiang" 3 => "G. Huang" 4 => "J. Lin" 5 => "L. Yang" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Diabetes Care" "fecha" => "2014" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.I. Hawa" 1 => "A.P. Buchan" 2 => "T. Ola" 3 => "C.C. Wun" 4 => "D.A. DeMicco" 5 => "W. Bao" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc13-2383" "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "2014" "volumen" => "37" "paginaInicial" => "1643" "paginaFinal" => "1649" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24722498" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rosiglitazone preserves ß-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:5 [ 0 => "Z. Yang" 1 => "Z. Zhou" 2 => "X. Li" 3 => "G. Huang" 4 => "J. Lin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Diab Res Clin Pract" "fecha" => "2009" "volumen" => "83" "paginaInicial" => "54" "paginaFinal" => "60" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Maruyama" 1 => "S. Tanaka" 2 => "A. Shimada" 3 => "O. Funae" 4 => "A. Kasuga" 5 => "A. Kanatsuka" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2007-2267" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2008" "volumen" => "93" "paginaInicial" => "2115" "paginaFinal" => "2121" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18397986" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interventions for latent autoimmune diabetes (LADA) in adults" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Brophy" 1 => "H. Davies" 2 => "S. Mannan" 3 => "H. Brunt" 4 => "R. Williams" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD006165.pub3" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2011" "volumen" => "9" "paginaInicial" => "CD006165" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21901702" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dipeptidyl peptidase 4 inhibitor sitagliptin maintains ß-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Zhao" 1 => "L. Yang" 2 => "Y. Xiang" 3 => "L. Liu" 4 => "G. Huang" 5 => "Z. Long" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2013-3633" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2014" "volumen" => "99" "paginaInicial" => "E876" "paginaFinal" => "E880" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24432999" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack121835" "titulo" => "Acknowledgments" "texto" => "<p id="par0050" class="elsevierStylePara elsevierViewall">The work behind this paper was prepared in the context the PhD Programme of the Autonomous University of Barcelona (“Doctorat en Medicina de la Universitat Autònoma de Barcelona”).</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "es" "url" => "/21735093/0000006200000001/v1_201501180031/S2173509315000033/v1_201501180031/es/main.assets" "Apartado" => array:4 [ "identificador" => "8587" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735093/0000006200000001/v1_201501180031/S2173509315000033/v1_201501180031/es/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509315000033?idApp=UINPBA00004N" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Octubre | 8 | 0 | 8 |
| 2024 Septiembre | 56 | 16 | 72 |
| 2024 Agosto | 31 | 4 | 35 |
| 2024 Julio | 20 | 1 | 21 |
| 2024 Junio | 32 | 1 | 33 |
| 2024 Mayo | 21 | 5 | 26 |
| 2024 Abril | 27 | 1 | 28 |
| 2024 Marzo | 45 | 7 | 52 |
| 2024 Febrero | 57 | 4 | 61 |
| 2024 Enero | 47 | 2 | 49 |
| 2023 Diciembre | 53 | 10 | 63 |
| 2023 Noviembre | 42 | 19 | 61 |
| 2023 Octubre | 33 | 10 | 43 |
| 2023 Septiembre | 16 | 0 | 16 |
| 2023 Agosto | 13 | 2 | 15 |
| 2023 Julio | 9 | 4 | 13 |
| 2023 Junio | 12 | 2 | 14 |
| 2023 Mayo | 21 | 5 | 26 |
| 2023 Abril | 31 | 5 | 36 |
| 2023 Marzo | 14 | 1 | 15 |
| 2023 Febrero | 10 | 2 | 12 |
| 2023 Enero | 16 | 2 | 18 |
| 2022 Diciembre | 9 | 7 | 16 |
| 2022 Noviembre | 24 | 6 | 30 |
| 2022 Octubre | 17 | 7 | 24 |
| 2022 Septiembre | 13 | 16 | 29 |
| 2022 Agosto | 7 | 11 | 18 |
| 2022 Julio | 14 | 10 | 24 |
| 2022 Junio | 16 | 7 | 23 |
| 2022 Mayo | 14 | 4 | 18 |
| 2022 Abril | 41 | 15 | 56 |
| 2022 Marzo | 51 | 18 | 69 |
| 2022 Febrero | 25 | 4 | 29 |
| 2022 Enero | 22 | 4 | 26 |
| 2021 Diciembre | 30 | 15 | 45 |
| 2021 Noviembre | 13 | 8 | 21 |
| 2021 Octubre | 10 | 8 | 18 |
| 2021 Septiembre | 10 | 10 | 20 |
| 2021 Agosto | 8 | 4 | 12 |
| 2021 Julio | 14 | 7 | 21 |
| 2021 Junio | 22 | 12 | 34 |
| 2021 Mayo | 15 | 5 | 20 |
| 2021 Abril | 68 | 3 | 71 |
| 2021 Marzo | 38 | 9 | 47 |
| 2021 Febrero | 15 | 6 | 21 |
| 2021 Enero | 21 | 6 | 27 |
| 2020 Diciembre | 14 | 8 | 22 |
| 2020 Noviembre | 21 | 5 | 26 |
| 2020 Octubre | 9 | 4 | 13 |
| 2020 Septiembre | 11 | 13 | 24 |
| 2020 Agosto | 12 | 6 | 18 |
| 2020 Julio | 9 | 10 | 19 |
| 2020 Junio | 8 | 9 | 17 |
| 2020 Mayo | 10 | 5 | 15 |
| 2020 Abril | 7 | 1 | 8 |
| 2020 Marzo | 18 | 5 | 23 |
| 2020 Febrero | 12 | 2 | 14 |
| 2020 Enero | 8 | 10 | 18 |
| 2019 Diciembre | 19 | 10 | 29 |
| 2019 Noviembre | 8 | 5 | 13 |
| 2019 Octubre | 8 | 4 | 12 |
| 2019 Septiembre | 21 | 9 | 30 |
| 2019 Agosto | 12 | 4 | 16 |
| 2019 Julio | 21 | 14 | 35 |
| 2019 Junio | 28 | 5 | 33 |
| 2019 Mayo | 98 | 27 | 125 |
| 2019 Abril | 6 | 6 | 12 |
| 2019 Marzo | 3 | 6 | 9 |
| 2019 Febrero | 9 | 4 | 13 |
| 2019 Enero | 2 | 0 | 2 |
| 2018 Diciembre | 2 | 4 | 6 |
| 2018 Noviembre | 2 | 0 | 2 |
| 2018 Octubre | 7 | 5 | 12 |
| 2018 Septiembre | 12 | 5 | 17 |
| 2018 Agosto | 6 | 2 | 8 |
| 2018 Julio | 9 | 2 | 11 |
| 2018 Junio | 3 | 1 | 4 |
| 2018 Mayo | 7 | 2 | 9 |
| 2018 Abril | 1 | 3 | 4 |
| 2018 Marzo | 7 | 0 | 7 |
| 2018 Febrero | 4 | 0 | 4 |
| 2018 Enero | 15 | 1 | 16 |
| 2017 Diciembre | 3 | 0 | 3 |
| 2017 Noviembre | 13 | 0 | 13 |
| 2017 Octubre | 9 | 1 | 10 |
| 2017 Septiembre | 8 | 0 | 8 |
| 2017 Agosto | 14 | 2 | 16 |
| 2017 Julio | 10 | 2 | 12 |
| 2017 Junio | 23 | 5 | 28 |
| 2017 Mayo | 24 | 11 | 35 |
| 2017 Abril | 26 | 1 | 27 |
| 2017 Marzo | 25 | 17 | 42 |
| 2017 Febrero | 45 | 3 | 48 |
| 2017 Enero | 7 | 1 | 8 |
| 2016 Diciembre | 18 | 5 | 23 |
| 2016 Noviembre | 22 | 3 | 25 |
| 2016 Octubre | 42 | 6 | 48 |
| 2016 Septiembre | 21 | 3 | 24 |
| 2016 Agosto | 14 | 6 | 20 |
| 2016 Julio | 12 | 1 | 13 |
| 2016 Junio | 16 | 11 | 27 |
| 2016 Mayo | 17 | 20 | 37 |
| 2016 Abril | 12 | 6 | 18 |
| 2016 Marzo | 22 | 11 | 33 |
| 2016 Febrero | 15 | 11 | 26 |
| 2016 Enero | 24 | 12 | 36 |
| 2015 Diciembre | 16 | 7 | 23 |
| 2015 Noviembre | 17 | 4 | 21 |
| 2015 Septiembre | 1 | 0 | 1 |
| 2015 Julio | 1 | 1 | 2 |
| 2015 Mayo | 1 | 1 | 2 |
| 2015 Febrero | 0 | 1 | 1 |
Mostrar todo
